SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer
- PMID: 31199986
- DOI: 10.1016/j.semcancer.2019.06.008
SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer
Abstract
The epithelial-mesenchymal transition (EMT) is a process of cell transformation under certain physiological and pathological states in which epithelial cells are transformed into mesenchymal cells with fibroblast-like properties, which confers upon them the increased invasion and migration capabilities of cancer cells. Previous studies have demonstrated that SRY-related high-mobility-group box 4 (Sox4) protein coordinates EMT-related pathways and EMT-related transcription factors, thereby regulating the EMT process. The focus of this review is to evaluate recent advances regarding the role of Sox4 protein in the cancer EMT. First, we provide an overview of the general background of Sox4 (structure and function) and the EMT in cancer. Next, we introduce the interactions between Sox4 protein and various factors during cancer EMT. Finally, we suggest directions for future investigations. In general, the information compiled in this paper should serve as a comprehensive repository of information on the subject matter and contribute to the design of other research and future efforts to develop therapeutic strategies that target the Sox4 protein.
Keywords: Cancer; Epithelial-mesenchymal transition; SRY-related high-mobility-group box 4.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
SOX4: Epigenetic regulation and role in tumorigenesis.Semin Cancer Biol. 2020 Dec;67(Pt 1):91-104. doi: 10.1016/j.semcancer.2019.06.022. Epub 2019 Jul 2. Semin Cancer Biol. 2020. PMID: 31271889 Review.
-
SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?Trends Cancer. 2017 Aug;3(8):571-582. doi: 10.1016/j.trecan.2017.06.002. Epub 2017 Jul 8. Trends Cancer. 2017. PMID: 28780934 Review.
-
MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.J Biosci. 2019 Dec;44(6):146. J Biosci. 2019. PMID: 31894127
-
ETS1 promoted cell growth, metastasis and epithelial-mesenchymal transition process in melanoma by regulating miR-16-mediated SOX4 expression.Melanoma Res. 2021 Aug 1;31(4):298-308. doi: 10.1097/CMR.0000000000000743. Melanoma Res. 2021. PMID: 34039939
-
Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.Int J Oncol. 2017 Jul;51(1):336-346. doi: 10.3892/ijo.2017.4010. Epub 2017 May 17. Int J Oncol. 2017. PMID: 28534986
Cited by
-
Retracted Article: Long noncoding RNA ANRIL knockdown increases sensitivity of non-small cell lung cancer to cisplatin by regulating the miR-656-3p/SOX4 axis.RSC Adv. 2019 Nov 26;9(66):38735-38744. doi: 10.1039/c9ra06993c. eCollection 2019 Nov 25. RSC Adv. 2019. Retraction in: RSC Adv. 2021 Feb 3;11(11):6255. doi: 10.1039/d1ra90074a. PMID: 35540191 Free PMC article. Retracted.
-
Circular RNA circ_0011385 promotes cervical cancer progression through competitively binding to miR-149-5p and up-regulating SOX4 expression.Kaohsiung J Med Sci. 2021 Dec;37(12):1058-1068. doi: 10.1002/kjm2.12432. Epub 2021 Aug 9. Kaohsiung J Med Sci. 2021. PMID: 34369654 Free PMC article.
-
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.Mol Cancer. 2020 Jun 17;19(1):106. doi: 10.1186/s12943-020-01220-7. Mol Cancer. 2020. PMID: 32552762 Free PMC article.
-
Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.Cancers (Basel). 2019 Nov 21;11(12):1841. doi: 10.3390/cancers11121841. Cancers (Basel). 2019. PMID: 31766574 Free PMC article. Review.
-
TNF-α modulates cell proliferation via SOX4/TGF-β/Smad signaling in benign prostatic hyperplasia.Cell Death Dis. 2025 Jul 1;16(1):472. doi: 10.1038/s41419-025-07783-x. Cell Death Dis. 2025. PMID: 40595502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical